Two specific targets, integrin αvβ3 and aminopeptidase N (APN or CD13), are highlighted due to their overexpression on both tumor cells and neovasculature, making them ideal for developing radioligands [41,42]. The gene discussed is ANPEP; the disease is neoplasm.